Bulk Pharmaceutical API Sources for benzyl benzoate

Bulk Pharmaceutical API Sources for benzyl benzoate

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		B9550_SIAL
Sigma-Aldrich		W213802_ALDRICH
Sigma-Aldrich		W213810_ALDRICH
Sigma-Aldrich		B6630_SIAL

Benzyl Benzoate Bulk Active Pharmaceutical Ingredient (API) Sourcing Landscape

Last updated: February 19, 2026

This analysis details the global supply of bulk Benzyl Benzoate active pharmaceutical ingredient (API). It identifies key manufacturers, production capacities, regulatory statuses, and market trends impacting availability for pharmaceutical formulations.

What is Benzyl Benzoate?

Benzyl Benzoate is an organic compound with the chemical formula C₁₄H₁₂O₂. It is an ester of benzyl alcohol and benzoic acid. Industrially, it is produced via the esterification of benzyl alcohol with benzoic acid or through the Tishchenko reaction of benzaldehyde.

Chemical and Physical Properties

• CAS Number: 120-51-4
• Molecular Weight: 212.24 g/mol
• Appearance: Colorless to pale yellow, viscous liquid.
• Odor: Faint, sweet, balsamic odor.
• Solubility: Practically insoluble in water. Soluble in alcohol, ether, chloroform, and fixed oils.
• Boiling Point: 323 °C (613 °F)
• Melting Point: 18–20 °C (64–68 °F)
• Density: 1.118 g/cm³

Primary Pharmaceutical Applications

Benzyl Benzoate is primarily used as an antiparasitic agent, effective against scabies and lice. It acts as a scabicide, killing mites and their eggs, and as a pediculicide, killing lice and their nits. Its use in pharmaceutical preparations is typically as a topical lotion or cream.

Global Manufacturing Landscape

The production of Benzyl Benzoate API is concentrated in regions with established chemical manufacturing infrastructure and access to raw materials.

Key Manufacturing Regions and Countries

• China: Dominant global producer, benefiting from cost advantages and large-scale chemical synthesis capabilities.
• India: Significant manufacturing hub with a strong pharmaceutical API sector and robust regulatory oversight.
• Europe: Several manufacturers in countries like Germany and France, often focusing on higher-purity grades and specialized applications.
• United States: Limited bulk production, with a focus on niche markets or specific regulatory requirements.

Major API Manufacturers

While specific production capacities are often proprietary, several companies are recognized as significant suppliers of Benzyl Benzoate API. These include:

• Jubilant Life Sciences (India): A prominent player in the global API market, with diverse manufacturing capabilities.
• Lanxess AG (Germany): Known for its specialty chemicals, including intermediates used in pharmaceutical production.
• BASF SE (Germany): A global chemical company with a broad portfolio, potentially including Benzyl Benzoate for various applications.
• Several Chinese Manufacturers: A fragmented landscape of manufacturers, including but not limited to:
  • Yantai Dihai Chemical Co., Ltd.
  • Shandong Luba Chemical Co., Ltd.
  • Zibo Shuangyuan Chemical Co., Ltd.

Production Capacities and Trends

Estimates of global Benzyl Benzoate API production capacity suggest a significant oversupply relative to current demand, particularly from Chinese manufacturers.

• Estimated Global Capacity: Exceeds 50,000 metric tons annually.
• Average Annual Demand: Estimated in the range of 10,000-15,000 metric tons.
• Trend: Capacity expansion in China has driven down prices. Manufacturers in Europe and India often compete on quality and regulatory compliance.

Regulatory and Quality Standards

Ensuring the quality and safety of Benzyl Benzoate API is critical for pharmaceutical applications. Compliance with international pharmacopoeias and regulatory guidelines is mandatory.

Pharmacopoeial Standards

Benzyl Benzoate API intended for pharmaceutical use must meet the specifications outlined in major pharmacopoeias:

• United States Pharmacopeia (USP): Sets standards for identity, strength, quality, and purity of medicines.
• European Pharmacopoeia (Ph. Eur.): Provides harmonized standards for medicinal substances in Europe.
• British Pharmacopoeia (BP): Standards for medicines used in the UK.
• Japanese Pharmacopoeia (JP): Standards for pharmaceutical products in Japan.

Key quality parameters typically include:

• Assay: Minimum 99.0% purity.
• Identification: Specific chemical tests to confirm identity.
• Related Substances: Limits on impurities such as benzyl alcohol, benzoic acid, and dibenzyl ether.
• Heavy Metals: Strict limits for toxic metal contaminants.
• Water Content: Typically very low.

Regulatory Filings and Certifications

Manufacturers seeking to supply Benzyl Benzoate API to regulated markets must obtain relevant certifications and maintain compliant filings.

• Drug Master Files (DMFs): Filed with regulatory agencies (e.g., U.S. Food and Drug Administration - FDA) to provide confidential detailed information about manufacturing facilities, processes, and quality controls.
• Certificate of Suitability to the Monographs of the European Pharmacopoeia (CEP): Issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), demonstrating compliance with Ph. Eur. monographs.
• Good Manufacturing Practice (GMP) Certification: Audited and certified by national regulatory authorities (e.g., FDA, EMA, Indian CDSCO) ensuring consistent production quality.

Notable Regulatory Statuses

• FDA Inspected Facilities: Manufacturers supplying to the U.S. market must have facilities that have undergone and passed FDA inspections.
• EMA Compliance: European manufacturers or those exporting to the EU must adhere to EMA guidelines.

Market Dynamics and Supply Chain Considerations

The Benzyl Benzoate API market is characterized by price sensitivity, quality variations, and logistical complexities.

Pricing Factors

• Raw Material Costs: Fluctuations in the cost of benzyl alcohol and benzoic acid directly impact API pricing.
• Manufacturing Location: Chinese suppliers generally offer lower prices due to lower labor and production overheads.
• Quality and Regulatory Compliance: API meeting USP, Ph. Eur., or other high-standard pharmacopoeial requirements commands higher prices.
• Volume: Large-volume orders typically receive discounts.
• Geopolitical Factors: Trade policies, tariffs, and shipping costs can influence landed prices.

Supply Chain Risks

• Geographic Concentration: Over-reliance on a single region (e.g., China) for a significant portion of supply creates vulnerability to supply disruptions (e.g., environmental regulations, plant shutdowns, trade disputes).
• Quality Control Variability: Differences in manufacturing standards and quality control across suppliers, especially from less regulated regions, can lead to batch-to-batch inconsistencies.
• Lead Times: Longer lead times for international shipments require careful inventory management.
• Raw Material Availability: Disruptions in the supply of key precursors can impact API production.

Import/Export Trends

• Major Importing Regions: North America, Europe, and other developed markets with stringent regulatory requirements.
• Major Exporting Regions: China and India are the primary global exporters of Benzyl Benzoate API.

Future Outlook and Strategic Sourcing

The market for Benzyl Benzoate API is expected to remain stable, driven by its established therapeutic uses. Strategic sourcing decisions will be critical for ensuring reliable, high-quality supply.

Demand Drivers

• Continued Use in Dermatology: Benzyl Benzoate remains a cost-effective and widely used treatment for scabies and lice.
• Emerging Markets: Increasing access to healthcare in developing nations may drive demand.
• Veterinary Applications: Use in animal health products also contributes to overall demand.

Sourcing Strategies

• Supplier Qualification: Rigorous qualification processes are essential, focusing on GMP compliance, audit history, and quality control procedures.
• Dual Sourcing: Establishing relationships with multiple qualified suppliers in different geographic regions mitigates supply chain risk.
• Long-Term Contracts: Securing favorable pricing and supply commitments through long-term agreements.
• Regulatory Support: Prioritizing suppliers with robust regulatory support, including up-to-date DMFs and CEPs.
• Auditing: Regular on-site audits of manufacturing facilities to verify ongoing compliance.

Potential Challenges

• Increasing Environmental Regulations: Stricter environmental controls in manufacturing regions, particularly China, could impact production costs and availability.
• Competition from Newer Therapies: While cost-effective, Benzyl Benzoate faces competition from newer antiparasitic agents, though its market share is expected to remain significant due to its price point.

Key Takeaways

• Benzyl Benzoate API production is heavily concentrated in China, with significant contributions from India and some European manufacturers.
• Global manufacturing capacity significantly exceeds current demand, leading to competitive pricing, particularly from Chinese suppliers.
• Pharmaceutical-grade Benzyl Benzoate API must adhere to stringent USP, Ph. Eur., and other pharmacopoeial standards, requiring robust GMP compliance and regulatory filings (DMFs, CEPs).
• Supply chain risks include geographic concentration, quality variability, and geopolitical factors.
• Strategic sourcing requires rigorous supplier qualification, dual sourcing, and a focus on regulatory compliance to ensure a reliable and high-quality API supply.

Frequently Asked Questions

What are the primary regulatory requirements for Benzyl Benzoate API intended for pharmaceutical use in the United States?

The API must meet the specifications outlined in the United States Pharmacopeia (USP) and be manufactured in facilities compliant with current Good Manufacturing Practices (cGMP). Manufacturers typically file a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA).

How does Benzyl Benzoate API pricing typically compare between Chinese and European manufacturers?

Chinese manufacturers generally offer lower prices due to lower production and labor costs. European manufacturers typically command higher prices, reflecting stringent quality controls, higher manufacturing standards, and adherence to rigorous regional regulatory requirements.

What are the main impurities to monitor in Benzyl Benzoate API and why are they critical?

Key impurities include benzyl alcohol, benzoic acid, and dibenzyl ether. These are critical because they can affect the safety and efficacy of the final pharmaceutical product. Pharmacopoeial standards set strict limits for these related substances.

How can pharmaceutical companies mitigate supply chain risks for Benzyl Benzoate API?

Mitigation strategies include qualifying multiple suppliers across different geographic regions, establishing long-term supply agreements, conducting regular site audits, and maintaining sufficient safety stock to buffer against potential disruptions.

Are there significant differences in Benzyl Benzoate API quality between manufacturers in India and China?

While both countries are major suppliers, manufacturers in India generally have a more established track record of meeting international regulatory standards and often undergo more frequent inspections by Western regulatory bodies. However, many Chinese manufacturers also produce high-quality, pharmacopoeial-grade API. A thorough supplier audit is essential regardless of the country of origin.

---

Citations

[1] United States Pharmacopeial Convention. (n.d.). United States Pharmacopeia. Retrieved from usp.org [2] European Directorate for the Quality of Medicines & HealthCare. (n.d.). European Pharmacopoeia. Retrieved from edqm.eu [3] Pharmaceutical Inspection Co-operation Scheme. (n.d.). PIC/S GMP Guide. Retrieved from picscheme.org